Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study.

Marco A.C. Versluis , Cindy Pielsticker , Maaike A. van der Aa , Marco de Bruyn
Oncology 95 ( 2) 100 -108

7
2018
Anti-cd103 antibodies

Marco De Bruyn , Klaas Jan-derek Kol , Hans Wilhelm Nijman , Hans Van Eenennaam

2023
2022-RA-1137-ESGO Use of an allogeneic, cell-based vaccine DCP-001 in high grade Serous Ovarian cancerpatients after primary treatment; A phase I clinical trial

Annegé Vledder , Hester van Zeeburg , Rob ten Pas , Anje Eerkens
International Journal of Gynecological Cancer 32 ( Suppl 2) A304 -A304

2022
Anti-cd103 antibodies

Marco DE BRUYN , KOL Jan-Derek , Hans NIJMAN , Hans Van Eenennaam

2021
FRESHLY ISOLATED AND CULTURED BLOOD DENDRITIC CELLS DISPLAY AN IMMATURE, RESPECTIVELY MATURE PHENOTYPE

MJ KLEIJMEER , HW NIJMAN , VMJ OORSCHOT , MA OSSEVOORT
JOURNAL OF CELLULAR BIOCHEMISTRY 12 -12

1995
INVITRO INDUCTION OF PRIMARY CTL RESPONSE AGAINST WILD-TYPE OR MUTANT P53 PEPTIDES

JGA HOUBIERS , HW NIJMAN , SH VANDERBURG , JW DRIJFHOUT
JOURNAL OF CELLULAR BIOCHEMISTRY 109 -109

1993
IMMUNOGENICITY OF ACTIVATED RAS ONCOGENES

A VANELSAS , H NIJMAN , C MELIEF , PI SCHRIER
JOURNAL OF CELLULAR BIOCHEMISTRY 138 -138

1993
Len Bowers1, Debra Jeffery2, Alan Simpson3, Christina Daly4, Jonathan Warren5 & Henk Nijman6

L BOWERS , D JEFFERY , A SIMPSON , C DALY
Journal Of Advanced Nursing 57 ( 2) 153 -160

2006
Frozen section diagnosis of borderline ovarian tumors with suspicious features of invasive cancer is a devil's dilemma for the surgeon: a systematic review and meta-analysis

Roy F P M Kruitwagen , Hans W Nijman , Joost Bart , Loes F S Kooreman
Acta Obstetricia et Gynecologica Scandinavica

2021
FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.

Hannah S van Meurs , Jurgen M J Piek , Glen R Monroe , Hans W Nijman
Gynecologic Oncology

7
2021
T cell infiltration and MHC I and II expression in the presence of tumor antigens: An immunohistochemical study in patients with serous epithelial ovarian cancer

Hans W Nijman , Paul J van Diest , Ria J.J Poort-Keesom , Silvia von Mensdorff-Pouilly
European Journal of Obstetrics & Gynecology and Reproductive Biology 94 ( 1) 114 -120

23
2001
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer

Lorena Alonso-Alconada , Laura Muinelo-Romay , Kadri Madissoo , Antonio Diaz-Lopez
Molecular Cancer 13 ( 1) 223 -223

64
2014
Targeted delivery of CD40L promotes restricted activation of antigen-presenting cells and induction of cancer cell death

Kim L Brunekreeft , Corinna Strohm , Marloes J Gooden , Anna A Rybczynska
Molecular Cancer 13 ( 1) 85 -85

19
2014
Myeloid derived suppressor cells—An overview of combat strategies to increase immunotherapy efficacy

Oana Draghiciu , Joyce Lubbers , Hans W Nijman , Toos Daemen
OncoImmunology 4 ( 1)

161
2015
Indoleamine-2,3-dioxygenase (IDO) metabolic activity is detrimental for cervical cancer patient survival

Debbie M Ferns , Ido P Kema , Marrije R Buist , Hans W Nijman
OncoImmunology 4 ( 2) 981457

84
2015
Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

Oana Draghiciu , Hans W Nijman , Baukje Nynke Hoogeboom , Tjarko Meijerhof
OncoImmunology 4 ( 3) e989764

70
2015
Role of regulatory T-cells in immunization strategies involving a recombinant alphavirus vector system

Mateusz Walczak , Joke Regts , Antoon JM van Oosterhout , Louis Boon
Antiviral Therapy 16 ( 2) 207 -218

15
2011